Patients with NYHA class IV decompensated cardiac failure. It is also contraindicated in bronchial asthma, second or third degree AV block, sick sinus syndrome, cardiogenic shock or severe bradycardia. Use of Carvedilol in patients with clinically manifest hepatic impairment is not recommended. Therapy is not to be initiated in severe heart failure.